Target intelligence / Profile preview

Zinc finger protein 663, pseudogene (ZNF663P)

Target
ZNF663P
Molecular classification
Pseudogene, Other (parent gene belongs to "Transcription factor" and "Zinc finger protein" family, but the pseudogene itself is not classified functionally)
01

Overview

Zinc finger protein 663, pseudogene (ZNF663P, also known as DKFZp547G0215), is a **pseudogene** of the zinc finger protein 663 gene family. Pseudogenes are genomic DNA sequences that resemble functional genes but typically do not code for functional proteins due to disabling mutations, truncations, or lack of regulatory elements[3][10]. While the parent zinc finger protein genes encode transcription factors involved in gene regulation, ZNF663P itself is not believed to produce a functional protein product and is thus generally considered nonfunctional[7][9]. Some pseudogenes exhibit regulatory functions at the RNA level, such as acting as competing endogenous RNAs (ceRNAs) or miRNA decoys, but there is no experimental evidence supporting a specific regulatory role for ZNF663P[2][6][8]. No known drugs act on ZNF663P, and it is not considered a therapeutic target. **Notes on functional context:** - As a pseudogene, ZNF663P does not belong to molecular families such as receptor, enzyme, transporter, or canonical transcription factor categories, but its sequence is related to zinc finger transcription factors[3][4][7]. - There is nothing "wrong" with this target in the sense of spelling or identification, but it is *not* a drug target; care should be taken not to confuse this pseudogene with its functional protein-coding parent gene ZNF663. - Should not be selected for therapeutic targeting, biomarker use, or functional annotation as an active protein.

Other names
ZNF663DKFZp547G0215
02

Biological functions

Potential regulatory RNA function (such as miRNA sponge or regulatory RNA), but lacks protein-coding function
03

Disease associations

Other (no direct validated links; general pseudogene involvement in cancer or regulatory processes through RNA mechanisms has been proposed, but specific disease roles for ZNF663P are not established)

Beyond the preview

Go deeper on Zinc finger protein 663, pseudogene (ZNF663P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 663, pseudogene (ZNF663P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call